Quick Takeaways
- This page summarizes Max Rosett's Form 4 filing for Immunome Inc. (IMNM).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 13 Aug 2024, 17:43.
Max Rosett - 09 Aug 2024 Form 4 Insider Report for Immunome Inc. (IMNM)
- Signature
- /s/ Sandra Stoneman, Attorney-in-Fact
- Issuer symbol
- IMNM
- Transactions as of
- 09 Aug 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 13 Aug 2024, 17:43:57 UTC
- Previous filing
- 17 May 2024
- Next filing
- 20 Sep 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Max Rosett filed Form 4 for Immunome Inc. (IMNM) on 13 Aug 2024."
What Changed
- Previous filing in this sequence was filed on 17 May 2024.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
IMNM
transaction
Derivative
Stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +190,000
- Change %
- Price
- $0.000000
- Shares after
- 190,000
- Date
- 09 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 190,000
- Exercise price
- $12.92
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 25% of the shares subject to the options vest on August 9, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter. |